Drupal.behaviors.print = function(context) {window.print();window.close();}>
VolitionRx Raises $1.2M for Clinical Trials of Cancer Dx
May 14, 2012
VolitionRx Raises $1.2M for Clinical Trials of Cancer Dx
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel
May 9, 2013 / GenomeWeb Daily News
Seegene, Selventa Partner on MDx Development for 'Underserved Markets'
April 23, 2013 / GenomeWeb Daily News
CollabRx, Sengenics Partner on Cancer Diagnostics
April 9, 2013 / GenomeWeb Daily News
CollabRx, OncoDNA Combining Technologies for Cancer Mutation Panels
April 4, 2013 / GenomeWeb Daily News
AmoyDx Cancer Detection Kit Approved by Chinese Regulators
March 20, 2013 / GenomeWeb Daily News